Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th February 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Norbrook Laboratories Ltd issues recall of anaesthetic
product recall
The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).
Coring issue reported for Propofol Emulsion for injection
 
Wholesalers and veterinary surgeons are being made aware of a product defect recall for Propofol Emulsion for Injection, which is manufactured by Norbrook Laboratories Ltd.

All batches of Propofol Emulsion for Injection 1.0% w/v that are currently on the market are being recalled, due to an issue of coring.

In a statement, the Veterinary Medicines Directorate (VMD) said: ‘An issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product and potentially being drawn up into the syringe upon extraction of the product from the vial. It may also result in the bung not resealing fully after use.’

The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).

For further information contact Mrs Deborah Curran on 028 3026 4435 or email deborah.curran@norbrook.co.uk

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.